Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis
Comparing Treatment With Food of Small Particle Size and Food of Large Particle Size in Subjects With Diabetic Gastroparesis. Evaluation of Diagnostic Methods. Determination of the Motility of Gastric Emptying After Intervention
1 other identifier
interventional
50
1 country
1
Brief Summary
The objective of the study is in subjects with Insulin Treated Diabetes Mellitus type 1 or 2 and gastroparesis:
- validate radiopaque markers with fluoroscopy with gastric scintigraphy method
- study the difference of metabolic control including the frequents of hypoglycaemia, gastrointestinal symptoms, quality of life and nutrition state during dietary treatment of food of small particle size compared with food of large particle size
- validate the radiopaque markers method and measurement of the blood glucose and gastrointestinal symptoms after a test meal, against the gastric scintigraphy
- determine if the function of gastric emptying can be improved after intervention
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Sep 2007
Longer than P75 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2007
CompletedFirst Submitted
Initial submission to the registry
March 16, 2012
CompletedFirst Posted
Study publicly available on registry
March 19, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedNovember 6, 2018
November 1, 2018
6.5 years
March 16, 2012
November 5, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Metabolic Control - HbA1c
22 weeks
Secondary Outcomes (1)
gastrointestinal symptoms - Questionnaire: Patient Assessment of upper Gastrointestinal Disorders Symptoms, Gastrointestinal Symptom Rating Scale
22 weeks
Study Arms (2)
Diabetic diet
PLACEBO COMPARATORControl group. Subjects with Insulin Treated Diabetes Mellitus and Gastroparesis. Diet: Food of large particle size during 20 weeks.
Diet food in small particle size
ACTIVE COMPARATORIntervention group: Subjects with Insulin Treated Diabetes and Gastroparesis. Intervention Diet: Food of small particle size during 20 weeks.
Interventions
Subjects with diabetes mellitus and gastroparesis. Insulin treatment. Dietary treatment with food of small particle size.
Follow 20 radiopaque markers throw the ventricle by X-ray.
Registered the gastric emptying after intervention. Comparing the registrations at the beginning and at the end of the study.
Measure the blood glucose response and gastrointestinal symptoms after a test meal
Eligibility Criteria
You may qualify if:
- diabetes type 1 or 2 and gastroparesis
- must be able to understand oral and verbal instructions
You may not qualify if:
- gastrointestinal surgery
- other gastrointestinal disease
- S-Creatinine \>150 umol/L
- mental disease
- cerebral disease
- collagen disease
- untreated endocrine disease
- anticholinergic drugs
- psychopharmacologic drugs
- opiates
- addiction to drugs as alcohol and narcotics
- vegetarian
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Goteborg Universitet, Sahlgrenska Academy, Sahlgrenska University Hospital
Gothenburg, SE 413 45, Sweden
Related Publications (1)
Olausson EA, Storsrud S, Grundin H, Isaksson M, Attvall S, Simren M. A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial. Am J Gastroenterol. 2014 Mar;109(3):375-85. doi: 10.1038/ajg.2013.453. Epub 2014 Jan 14.
PMID: 24419482DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Magnus Simrén, M.D., Ph.D.
Inst of Medicine, Sahlgrenska Academy, Göteborg University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2012
First Posted
March 19, 2012
Study Start
September 1, 2007
Primary Completion
March 1, 2014
Study Completion
March 1, 2014
Last Updated
November 6, 2018
Record last verified: 2018-11